{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:53:37Z","timestamp":1792727617975,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-24-CE17-7220"],"award-info":[{"award-number":["ANR-24-CE17-7220"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["847507"],"award-info":[{"award-number":["847507"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/MED-OUT\/1112\/2021"],"award-info":[{"award-number":["PTDC\/MED-OUT\/1112\/2021"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PMTargets\/0003\/2024"],"award-info":[{"award-number":["PMTargets\/0003\/2024"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["LA\/P\/0050\/2020"],"award-info":[{"award-number":["LA\/P\/0050\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/50026\/2020"],"award-info":[{"award-number":["UIDP\/50026\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010434","name":"'la Caixa' Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.cmi.2025.08.030","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:39:25Z","timestamp":1756946365000},"page":"729-739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Aspergillus and host-pathogen interaction: focus on treatment-relevant aspects"],"prefix":"10.1016","volume":"32","author":[{"given":"Romain","family":"Manchon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Feys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hoenigl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank L.","family":"van de Veerdonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Lanternier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Wauters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostinho","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Serris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Delli\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2025.08.030_bib1","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/s41579-025-01180-z","article-title":"Aspergillus fumigatus biology, immunopathogenicity and drug resistance","volume":"23","author":"van de Veerdonk","year":"2025","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.cmi.2025.08.030_bib2","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S2213-2600(24)00151-6","article-title":"Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients","volume":"12","author":"Feys","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cmi.2025.08.030_bib3","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00134-025-07797-1","article-title":"Invasive fungal infections in patients with liver disease: Immunological and clinical considerations for the intensive care unit","volume":"51","author":"Epelbaum","year":"2025","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2025.08.030_bib4","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/cid\/ciae337","article-title":"Risk factors and outcome associated with fungal infections in patients with severe burn injury: 10-year retrospective IFI-BURN study","volume":"79","author":"Dudoignon","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.08.030_bib5","article-title":"Epidemiological characteristics of patients with invasive pulmonary aspergillosis infected with Aspergillus fumigatus from a tertiary hospital in Ningxia, China","volume":"15","author":"Kang","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.cmi.2025.08.030_bib6","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1128\/IAI.73.1.494-503.2005","article-title":"Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis","volume":"73","author":"Balloy","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.cmi.2025.08.030_bib7","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/QCO.0000000000000662","article-title":"Aspergillus fumigatus and pan-azole resistance: Who should be concerned?","volume":"33","author":"Wiederhold","year":"2020","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.cmi.2025.08.030_bib8","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 Update by the infectious diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.08.030_bib9","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.4049\/jimmunol.1501811","article-title":"Human neutrophils use different mechanisms to kill Aspergillus fumigatus conidia and hyphae: evidence from phagocyte defects","volume":"196","author":"Gazendam","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.cmi.2025.08.030_bib10","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1086\/513961","article-title":"Granulocyte colony-stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens","volume":"175","author":"Liles","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2025.08.030_bib11","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1128\/iai.61.4.1185-1193.1993","article-title":"Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon","volume":"61","author":"Roilides","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.cmi.2025.08.030_bib12","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jtct.2024.01.060","article-title":"Granulocyte-macrophage colony-stimulating factor in allogenic hematopoietic stem cell transplantation: from graft-versus-host disease to the graft-versus-tumor effect","volume":"30","author":"Bernardi","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.cmi.2025.08.030_bib13","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1200\/JCO.2014.60.5121","article-title":"Effect of granulocyte-macrophage colony-stimulating factor on prevention and treatment of invasive fungal disease in recipients of allogeneic stem-cell transplantation: a prospective multicenter randomized phase IV trial","volume":"33","author":"Wan","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cmi.2025.08.030_bib14","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1200\/JCO.2006.08.8823","article-title":"Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review","volume":"25","author":"Kuderer","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cmi.2025.08.030_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac535","article-title":"Recombinant human granulocyte-macrophage colony-stimulating factor (rhu GM-CSF) as adjuvant therapy for invasive fungal diseases","volume":"9","author":"Chen","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2025.08.030_bib16","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/jac\/dki252","article-title":"Experimental systemic murine aspergillosis: treatment with polyene and caspofungin combination and G-CSF","volume":"56","author":"Sionov","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2025.08.030_bib17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/02681219680000101","article-title":"Granulocyte-macrophage colony-stimulating factor and interferon-gamma prevent dexamethasone-induced immunosuppression of antifungal monocyte activity against Aspergillus fumigatus hyphae","volume":"34","author":"Roilides","year":"1996","journal-title":"J Med Vet Mycol"},{"key":"10.1016\/j.cmi.2025.08.030_bib18","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1111\/j.1600-6143.2010.03094.x","article-title":"Exogenous interferon-\u03b3 immunotherapy for invasive fungal infections in kidney transplant patients","volume":"10","author":"Armstrong-James","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cmi.2025.08.030_bib19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/cncr.21142","article-title":"Immunomodulation with interferon-gamma and colony-stimulating factors for refractory fungal infections in patients with leukemia","volume":"104","author":"Dignani","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.cmi.2025.08.030_bib20","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1471-2334-14-166","article-title":"Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series","volume":"14","author":"Delsing","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2025.08.030_bib21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJM199102213240801","article-title":"A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease","volume":"324","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2025.08.030_bib22","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/bmt.2008.237","article-title":"Randomized phase III study of granulocyte transfusions in neutropenic patients","volume":"42","author":"Seidel","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cmi.2025.08.030_bib23","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1182\/blood-2015-05-645986","article-title":"Efficacy of transfusion with granulocytes from G-CSF\/dexamethasone\u2013treated donors in neutropenic patients with infection","volume":"126","author":"Price","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2025.08.030_bib24","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/annonc\/mdt110","article-title":"Granulocyte transfusions in hematologic malignancy patients with invasive pulmonary aspergillosis: outcomes and complications","volume":"24","author":"Raad","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cmi.2025.08.030_bib25","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/JLB.4HI1221-722R","article-title":"Transfusable neutrophil progenitors as cellular therapy for the prevention of invasive fungal infections","volume":"111","author":"Sykes","year":"2022","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.cmi.2025.08.030_bib26","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41577-022-00826-w","article-title":"Immune responses to human fungal pathogens and therapeutic prospects","volume":"23","author":"Lionakis","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cmi.2025.08.030_bib27","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1086\/315142","article-title":"Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses","volume":"180","author":"Cenci","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2025.08.030_bib28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1365-2567.2009.03211.x","article-title":"Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity","volume":"130","author":"Chai","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.cmi.2025.08.030_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074326","article-title":"Characterization of specific immune responses to different Aspergillus antigens during the course of invasive aspergillosis in hematologic patients","volume":"8","author":"Potenza","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2025.08.030_bib30","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1182\/blood-2002-01-0265","article-title":"Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies","volume":"100","author":"Hebart","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2025.08.030_bib31","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1128\/IAI.05939-11","article-title":"Dectin-1-dependent interleukin-22 contributes to early innate lung defense against Aspergillus fumigatus","volume":"80","author":"Gessner","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.cmi.2025.08.030_bib32","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1002\/eji.200737409","article-title":"IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance","volume":"37","author":"Zelante","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cmi.2025.08.030_bib33","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1182\/blood-2005-04-1660","article-title":"Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus","volume":"107","author":"Beck","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2025.08.030_bib34","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1182\/blood-2005-05-1775","article-title":"Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation","volume":"106","author":"Perruccio","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2025.08.030_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abh1209","article-title":"CAR T cells targeting Aspergillus fumigatus are effective at treating invasive pulmonary aspergillosis in preclinical models","volume":"14","author":"Seif","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.cmi.2025.08.030_bib36","doi-asserted-by":"crossref","first-page":"10660","DOI":"10.1073\/pnas.1312789111","article-title":"Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection","volume":"111","author":"Kumaresan","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cmi.2025.08.030_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.659752","article-title":"CcpA- and Shm2-pulsed myeloid dendritic cells induce T-cell activation and enhance the neutrophilic oxidative burst response to Aspergillus fumigatus","volume":"12","author":"Page","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.cmi.2025.08.030_bib38","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1182\/blood-2003-03-0748","article-title":"A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation","volume":"102","author":"Bozza","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2025.08.030_bib39","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3390\/jof6040231","article-title":"Using expanded natural killer cells as therapy for invasive aspergillosis","volume":"6","author":"Soe","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.cmi.2025.08.030_bib40","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41573-022-00476-6","article-title":"Engineering the next generation of cell-based therapeutics","volume":"21","author":"Bashor","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.cmi.2025.08.030_bib41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13054-016-1182-z","article-title":"T cells from patients with Candida sepsis display a suppressive immunophenotype","volume":"20","author":"Spec","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2025.08.030_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq6682","article-title":"A B1a-natural IgG-neutrophil axis is impaired in viral- and steroid-associated aspergillosis","volume":"14","author":"Sarden","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.cmi.2025.08.030_bib43","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s11046-023-00742-0","article-title":"Humoral immunity against Aspergillus fumigatus","volume":"188","author":"Delli\u00e8re","year":"2023","journal-title":"Mycopathologia"},{"key":"10.1016\/j.cmi.2025.08.030_bib44","doi-asserted-by":"crossref","first-page":"6400","DOI":"10.1128\/AAC.01000-12","article-title":"Effect of PTX3 and voriconazole combination in a rat model of invasive pulmonary aspergillosis","volume":"56","author":"Lo Giudice","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2025.08.030_bib45","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1038\/s41467-021-24021-y","article-title":"Serum amyloid P component is an essential element of resistance against Aspergillus fumigatus","volume":"12","author":"Doni","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.cmi.2025.08.030_bib46","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3109\/13693780903117473","article-title":"Collectins and fungal pathogens: roles of surfactant proteins and mannose binding lectin in host resistance","volume":"48","author":"Brummer","year":"2010","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2025.08.030_bib47","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1001\/jama.2018.6129","article-title":"Effect of recombinant human pentraxin 2 vs placebo on change in forced vital capacity in patients with idiopathic pulmonary fibrosis: a randomized clinical trial","volume":"319","author":"Raghu","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2025.08.030_bib48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1182\/blood.V126.23.56.56","article-title":"PRM-151 in myelofibrosis: Durable efficacy and safety at 72 weeks","volume":"126","author":"Verstovsek","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2025.08.030_bib49","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1084\/jem.20150282","article-title":"The soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cells","volume":"213","author":"Chorny","year":"2016","journal-title":"J Exp Med"},{"key":"10.1016\/j.cmi.2025.08.030_bib50","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/archsurg.1992.01420010065009","article-title":"A randomized prospective trial of acyclovir and immune globulin prophylaxis in liver transplant recipients receiving OKT3 therapy","volume":"127","author":"Stratta","year":"1992","journal-title":"Arch Surg"},{"key":"10.1016\/j.cmi.2025.08.030_bib51","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.3390\/ijms23105563","article-title":"Monoclonal antibodies and invasive aspergillosis: diagnostic and therapeutic perspectives","volume":"23","author":"Lian","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cmi.2025.08.030_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.670578","article-title":"Vaccine-induced protection in two murine models of invasive pulmonary aspergillosis","volume":"12","author":"Rayens","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.cmi.2025.08.030_bib53","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02328-22","article-title":"Vaccination with live or heat-killed Aspergillus fumigatus \u0394sglA conidia fully protects immunocompromised mice from invasive aspergillosis","volume":"13","author":"Fernandes","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.cmi.2025.08.030_bib54","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","author":"Lampertico","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.cmi.2025.08.030_bib55","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-2600(24)00405-3","article-title":"Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials","volume":"13","author":"Smit","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cmi.2025.08.030_bib56","first-page":"CD006150","article-title":"Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection","volume":"2015","author":"Ewald","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2025.08.030_bib57","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cmi.2024.11.017","article-title":"Revisiting diagnostics: immune markers to diagnose invasive pulmonary aspergillosis","volume":"31","author":"Feys","year":"2025","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2025.08.030_bib58","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13613-022-01051-3","article-title":"A stratification strategy to predict secondary infection in critical illness-induced immune dysfunction: the REALIST score","volume":"12","author":"Tremblay","year":"2022","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.cmi.2025.08.030_bib59","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1211161","article-title":"Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation","volume":"370","author":"Cunha","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2025.08.030_bib60","doi-asserted-by":"crossref","first-page":"5394","DOI":"10.1182\/blood-2010-04-279307","article-title":"Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity","volume":"116","author":"Cunha","year":"2010","journal-title":"Blood"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X25004288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X25004288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T09:19:27Z","timestamp":1776158367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X25004288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1198743X25004288"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2025.08.030","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspergillus and host-pathogen interaction: focus on treatment-relevant aspects","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2025.08.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}